The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence–based biomarkers of response to immunotherapy in patients with non–small-cell lung cancer considering previous lines of treatment.
 
Pablo Iriso
Employment - Ariana Pharma
 
Jawad Boulahfa
Employment - Ariana Pharma
 
Mohammad Afshar
Leadership - Ariana Pharma
Stock and Other Ownership Interests - Ariana Pharma; Omicure
Research Funding - Anavex Life Sciences (Inst); Sanofi (Inst)
 
Valéry Attignon
No Relationships to Disclose
 
Jebrane Bouaoud
No Relationships to Disclose
 
Maxime Boussageon
No Relationships to Disclose
 
Jerome Fayette
Honoraria - AstraZeneca; Bristol-Myers Squibb; Hookipa Pharma; Merck Serono; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Elevar Therapeutics; Hookipa Pharma; ITeos Therapeutics; Merck Serono; Merck Sharp & Dohme; Seagen
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Jean-Philippe Foy
No Relationships to Disclose
 
Andy Karabajakian
No Relationships to Disclose
 
Martin Kindermans
Employment - Ariana Pharma
 
Sylvie Lantuejoul
No Relationships to Disclose
 
Lucas Michon
No Relationships to Disclose
 
Maurice Perol
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daïchi Sankyo; GlaxoSmithKline; Gritstone Bio; Janssen Oncology; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Merck Sharp & Dohme; Pfizer; Roche; Takeda
 
Sandra Ortiz-Cuaran
No Relationships to Disclose
 
Frédéric Parmentier
Employment - Ariana Pharma
Leadership - Ariana Pharma
Stock and Other Ownership Interests - Ariana Pharma
 
Aurélie Swalduz
Honoraria - Amgen; AZD; Boehringer Ingelheim; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Janssen; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Janssen
 
Thomas Turcat
Employment - OmiCure
Leadership - OmiCure
Stock and Other Ownership Interests - OmiCure
 
Pierre Saintigny
Honoraria - Archer; Bristol Myer Squibb; HTG Molecular Diagnostics; Inivata; Roche Molecular Diagnostics
Research Funding - AstraZeneca; BMS Foundation; Illumina; Novartis; Omicure (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myer Squibb; Illumina; Roche